In vivo measurement of local tissue characteristics by modern bioimaging techniques such as positron emission tomography (PET) provides the opportunity to analyze quantitatively the role that tissue heterogeneity may play in understanding biological function. This paper develops a statistical measure of the heterogeneity of a tissue characteristic that is based on the deviation of the distribution of the tissue characteristic from a unimodal elliptically contoured spatial pattern. An efficient algorithm is developed for computation of the measure based on volumetric region of interest data. The technique is illustrated by application to data from PET imaging studies of fluorodeoxyglucose utilization in human sarcomas. A set of 74 sarcoma patients (with five-year follow-up survival information) were evaluated for heterogeneity as well as a number of other potential prognostic indicators of survival. A Cox proportional hazards analysis of these data shows that the degree of heterogeneity of the sarcoma is the major risk factor associated with patient death. Some theory is developed to analyze the asymptotic statistical behavior of the heterogeneity estimator. In the context of data arising from Poisson deconvolution (PET being the prime example), the heterogeneity estimator, which is a non-linear functional of the PET image data, is consistent and converges at a rate that is parametric in the injected dose.
INTRODUCTION
The measurement of local biochemical and physiological characteristics of tissue in vivo with imaging techniques such as emission tomography, fluorescence cytometry, magnetic resonance spectroscopy and ultrasound techniques provide the ability to examine the role which heterogeneity may play in the biology of both normal and pathological tissue. Figure 1 shows some positron emission tomography (PET) images of flourodeoxyglucose (FDG) utilization in human sarcomas obtained on a GE Advance scanner at the University of Washington Medical Center in Seattle. The imaged volume for the four tumors varied from between 35 and 105 contiguous cross-sectional slices (about 5 mm thick) through the tumor region. Each transverse image consists of 128 × 128 pixels each with a 2.1 × 2.1 mm resolution. The outlines of tumor regions, indicated on the images, were identified with reference to conventional radiological information (CT scans). The data in Figure 1 demonstrate substantial variation in the distribution of FDG utilization within the tumor regions, assessed in the patients at presentation. These examples show that the FDG distribution in the high-grade femur sarcoma and the soft-tissue upper arm sarcoma are more compact than the soft-tissue thigh and pelvic tumors. In qualitative terms the latter two tumors have a more spatially heterogeneous pattern of FDG utilization.
In an oncologic setting, where most modern treatments attempt to eliminate tumor cell populations, heterogeneity in the biological aggressiveness of the tumor cell populations is likely to play an important role in predicting treatment success. The treatment of a well-defined homogeneous tumor is almost always more effective than that of a diffuse tumor mass. Heterogeneity has arisen as an important concept in brain and heart imaging (Tiihonen et al., 1997; Wieneke et al., 1999) ; and also at the level of cellular imaging-see Wang (2000) for example.
Surprisingly, there has been little work on the development of measures of heterogeneity for biomedical imaging data. Techniques developed for analyzing properties of point patterns, e.g. Diggle (1983) , might be appropriate in situations where the measured tissue characteristic is categorical in nature. When the measured characteristic is continuous, as is our focus here, conversion to point patterns by simple thresholding will necessarily ignore potentially important quantitative information. Our experience with the approach has been that the selection of an appropriate threshold level is far from straightforward. Thresholding with too high a level results in no point patterns for some images; too low a level creates uniform point patterns for all images. From a technical point of view, there is little formal guidance at present of how uncertainties in image data propagate to create uncertainties in an associated point-pattern obtained by thresholding. Thus, even if it were possible to construct a plausible quantitative measure of heterogeneity based on a derived point-pattern, a statistical understanding of how the accuracy of this measure depended on the reliability of the underlying image data would be quite difficult to determine. This paper develops a statistical measure of heterogeneity of the tissue uptake of a radiotracer which is based on the deviation of the measured tissue uptake from a specified structural form-an elliptically contoured pattern. The measure is described in detail in Section 2 together with a description of an algorithm for practically implementing the approach. The technique is applied to data from the University of Washington PET sarcoma studies in Section 3. Included in this section is an evaluation, based on the analysis of a set of 74 sarcoma patients, of the prognostic potential of the heterogeneity measure. A Cox proportional hazards survival analysis suggests that the heterogeneity of the sarcoma is the major risk factor for patient death. A statistical analysis of the behavior of the heterogeneity estimator as a function of the reliability of the underlying image data is developed in Section 4. The results presented show that under reasonable assumptions on the smoothness of the underlying source distribution, the asymptotic behavior of the heterogeneity estimator, which is a non-linear functional of the image data, is parametric in nature. The paper concludes with some discussion, including directions for possible generalizations of the approach. Proofs of Theorems 1 and 2 in the paper are available from the website http://www.biostatistics.oupjournals.org.
METHODOLOGY
The data set consists of an array {(z i , x i ), i = 1, 2, . . . , N } corresponding to measurements of the quantitated tissue characteristic (z) and the 3D spatial coordinates (x) of N tissue volume elements (voxels) in the region of interest (ROI), ⊂ R 3 . Our measure of heterogeneity is based on the departure of the observed data in the ROI from a simple idealized structure. The idealized structure is defined as one in which the measured tissue characteristic follows an elliptical pattern. Specifically, for the idealized structure the tissue characteristic within the ROI is given by a function
for some monotonic decreasing level function g and a positive definite covariance matrix . Clearly, the level sets of the idealized structure are elliptical. The size, location and shape of these elliptical level sets will be determined by the level function g, the center point µ, and the covariance matrix . Mathematically, the scale of and g are interchangeable so there is a non-uniqueness in the parametrization of the idealized structure. To remove this we introduce a scaling which requires that g be a function on the unit interval. We define a contour coordinate function t (x|θ) for x ∈ (the ROI) by
where θ uniquely determines (µ, ) (see Section 2.2). The idealized structure is now given by
for some monotone decreasing function g defined on [0, 1]. Note that g need not necessarily be strictly decreasing. The uniqueness of the idealized structure can be established under the following conditions.
C.1
The monotone decreasing function g is not constant and for some l ∈ (g(0),
The first condition requires that there is an elliptical level set of the idealized structure contained in the ROI; the size of this level set relative to the volume of the ROI may be arbitrarily small. The second condition would tend to exclude ROIs that comprise highly disjoint subregions. A convex or star-shaped ROI (relative to the point µ ∈ ) would present no problem. We have the following result.
THEOREM 1 An idealized structure λ I (x i ) = g(t (x|θ)) satisfying conditions C.1 and C.2 is uniquely parameterized.
Heterogeneity measure
The measure of heterogeneity is defined as the lack of fit of the best fitting idealized structure to the ROI data. Letẑ i =ĝ(t (x i | θ) for i = 1, 2, . . . , N be the tissue characteristic predicted by the best fitting idealized structure. Here we suppose thatĝ, and θ = ( µ, ) have been adjusted to minimize a residual sum of squares misfit from the observed data. Thus
where
Heterogeneity (ψ) is defined as the fraction of the residual sum of squares unexplained by the idealized structure, i.e.ψ
Provided (ĝ, θ) lies in the interior of the set of admissible (g, θ) values, a necessary condition for the minimum is that the directional derivative of the residual sum of squares function with respect to functions g is zero. This yields the variational or score equation:
which implies the familiar decomposition of the total sum of squares into the model and residual sums of squares:
It follows that the heterogeneity is simply related to the R 2 for the fit of the idealized structure: with
, the model sum of squares divided by the total sum of squares,ψ
Obviously heterogeneity must always lie in the interval [0, 1] and if the tissue characteristic is constant in the ROI, then the heterogeneity will be zero. The 3D orientation and shape of the idealized structure is determined by the matrix . In general the orientation of this matrix is not important as it depends on how the tissue volume is positioned relative to the bio-imaging apparatus. The eigenvalues of determine the shape or morphology of the idealized structure. If the eigenvalues are equal then the idealized structure is spherical. Deviations from this will arise when the structure has a more elongated shape.
Further interpretation.
While the shape of the idealized structure contributes to the above definition of heterogeneity, it should be noted thatψ is not merely an evaluation of the morphology of the ROI. For example if the z-values within the ROI are constant then, regardless of the shape of the ROI, theψ will be minimal (in fact zero). Neither should the heterogeneity measure be regarded as a measure of smoothness of the data within the ROI, as even a simple planar distribution of the quantitated tissue characteristic within the ROI (i.e. z i is an exact linear function of the 3D spatial coordinate x i ) can producê ψ-heterogeneity values that are arbitrarily close to unity. Theψ-heterogeneity value measures departure from an idealized elliptically contoured structure for the distribution of the quantitated tissue characteristic within the 3D ROI. Morphology and smoothness are factors which can contribute to the degree of departure, but should not be regarded as its sole determinants. In the context of human tumors (such as sarcomas shown in Figure 1 ), if there is a high degree of conformity to the idealized elliptical pattern (i.e. low heterogeneity), then it is reasonable to assume that the tumor will be well suited to standard treatments such as surgical resection or radiation therapy. Thus we would expect theψ-heterogeneity to have a relation to prognosis. This is borne out in Section 3.
Computation
The practical implementation of the heterogeneity measure requires an algorithm for evaluation of the best fitting idealized structure approximation. This involves minimization of the residual sum of squares criterion, RSS(θ, g). An eight-dimensional parametrization for θ is used, θ = (µ, σ, φ). The first component of θ generates the 3D location µ; the other components determine the covariance matrix subject to the constraint that has unit trace. This is achieved as follows:
Also we have the linear bound constraints: 0 σ 1 , σ 2 ; σ 2 1 + σ 2 2 1 and −1 φ 1 , φ 2 , φ 3 1. It is easily verified that all possible legitimate covariance matrices can be expressed in this form. The components of µ are constrained to lie within a rectangular region of the initial guess (described below). For any fixed θ , the classical algorithm of Barlow et al. (1972) implemented in the freely available code of Brown (1989) , is used to compute a monotone level function estimateĝ θ . Thus the residual sum of squares is reduced to a function of θ alone,
This reduction greatly simplifies the computation. The minimization of the reduced criterion with respect to θ is now a non-linear least-squares optimization problem. The constraints on µ, σ and φ are implemented using standard multinomial and logistic transformations (McCullagh and Nelder, 1983) . We use the code of Dennis et al. (1981) for computation of the solution. Throughout this computation the gradients are computed numerically.
Initialization. The starting point for the iteration is an initial guess for θ . This guess is based on the mean and covariance of a 3D probability mass function derived from the data, i.e. the initial guesses for µ and are
The motivation for these estimators arises from consideration of the case where the data might closely follow the ideal structure.
and is the ROI. By a similar process
If we extendḡ to a probability density function on R 3 and replace the volume with R 3 we have
The latter two integrals can be evaluated directly to obtain µ and a matrix proportional to . Hence we have µ (0) ≈ µ and (0) ∝ . Note that an initialization which is proportional to is sufficient based on the specification of the contour coordinate function given above.
2.2.1
Remarks. The present computer implementation of the algorithm can readily handle ROIs with up to 200 000 voxels. In practical terms, for applications to PET this is more than adequate. We have applied the approach to data from sarcomas which are among the largest classes of human tumors. The largest sarcoma ROI encountered so far had less than 50 000 voxels. The present computer implementation of the algorithm could be modified to process certain arrays out of core memory. This would enable the algorithm to be applied to much larger ROI sizes, should there be a practical need. General conditions for the convergence of the Gauss-Newton algorithm used in the code of Dennis et al. (1981) are well documented-see Ortega (1970) for example. Given the substantial non-linearities, it is difficult to check if those conditions hold in the situation at hand. We have carried out limited numerical tests (profiling the objective function in random directions through the parameter space for the purpose of identifying the existence of multiple minima) to examine the sensitivity of the Gauss-Newton algorithm to starting values for parameters. These tests did not reveal multiple minima, but we have no analytic results to support this for every possible data set. The proposed initialization procedure has the advantage of removing sensitivity due to starting guesses. Our experience with the scheme, based on several hundred applications to real and simulated data sets, has been highly satisfactory, numerical convergence typically occurring in fewer than 10 iterations (less than 1 min of CPU time on a 400 MHz processor) for all the data sets we have examined. We will show in the next section that the computed heterogeneity values, even if sub-optimal in the sense of not defining a global minimum ofψ, have substantial practical potential in the context of predicting survival for patients with sarcoma.
APPLICATION TO PET SARCOMA DATA
We begin this section by illustrating the heterogeneity analysis on the four PET sarcoma data sets shown in Figure 1 . We go on to report on an evaluation of the prognostic potential of the heterogeneity measure based on a set of 74 sarcoma patients in which we have survival information based on five year follow-up. The heterogeneity values for the data in Figure 1 are presented in Table 1 . Tumors A and C show substantially higher heterogeneities than tumors B and D. The maximum standardized uptake value (SUV) for FDG within the tumor region are also presented. The SUV is a measure of FDG uptake which is adjusted for the injected dose and the patient weight. Previous work has shown that in a large population SUV values are well correlated with tumor grade (a histologic measure of aggressiveness) and may also have value in predicting survival (Eary et al., 1998 (Eary et al., , 2002 . The survival characteristics of the four patients corresponding to the data in Figure 1 are shown in Table 1 . It is noteworthy that the most favorable survival times are obtained with tumors B and D (the latter continues to live) and these two tumors are found to have the lowest heterogeneity values. This result is reinforced by a more rigorous analysis presented in Section 3.1. The tumor shape characteristics are conveyed by the relative magnitudes of the eigenvalues (λ 2 /λ 1 and λ 3 /λ 1 where λ 1 is the largest eigenvalue) of the fitted covariance matrices (ˆ ). From Table  1 we see that tumor A shows the greatest deviation from a spherical shape, whilst tumor D is the most spherical. The estimated level functionsĝθ (t (x i |θ)) are presented in Figure 2 together with the PET data z i ordered by t (x i |θ). The lack of conformity of tumors A and C to the idealized model is clearly evident, hence the high heterogeneities. In contrast both tumors B and D show remarkable agreement with the idealized model and so achieve much lower heterogeneities.
Relationship between heterogeneity and other factors and patient survival
Heterogeneity values were calculated for a set of 74 sarcoma patients analyzed for FDG utilization with PET at the University of Washington. Five year follow-up survival information was available for the 74 patients of whom 36 died. A plot of the survival characteristics for patients with sarcomas showing above or below 10% heterogeneity is given in Figure 3 curves is highly significant (the p-value of the log-rank test is 0.025). A comprehensive analysis of the relationship between patient survival and a set of potential prognostic factors measured at the time of the PET scan was carried out. A total of 11 potential prognostic factors were considered. The factors included were patient age, weight and sex; tumor grade (low, median or high) and type (bone or soft tissue) determined by histological analysis of biopsy samples; a set of six measurements of the tumor volume based on the PET FDG data (maximum SUV, standard deviation of the SUV values, tumor volume, tumor shape characteristics, λ 2 /λ 1 and λ 3 /λ 1 , and tumor heterogeneity). The relationship between the potential prognostic factors and patient survival was examined using a multivariate Cox proportional hazards survival analysis as implemented in S-plus (MathSoft, 1999) . Starting with a model in which all variables were included, a sequence of models were obtained by successive elimination of the least important variables. If only statistically significant terms are retained, then the final model only includes heterogeneity ( p-value for the associated Cox-model coefficient is 0.0017). In addition, in each of the sequence of 11 models examined, heterogeneity was found to be highly significant with p-values always below 0.005. Table 2 are standardized. However, the MAD values for the variables are listed in Table 2 so that scaled coefficients can also be determined. Table 2 indicates that for patients of a given age with a tumor of a given level of aggressiveness (fixed maximum SUV value), a 0.074 increase in the level of heterogeneity of the tumor is associated with an estimated 87% increase in the risk of death. This is clearly an effect of substantial clinical relevance. The estimated effect of the tumor maximum SUV is somewhat interesting. In the absence of the heterogeneity indicator, tumors with larger maximum SUV values are found to have a greater risk of death (Eary et al., 2002) ; however, the presence of the heterogeneity measure changes the role of the maximum SUV information in predicting survival. Table 2 shows that for fixed degree of heterogeneity there is improved prognosis for the more aggressive tumors. A possible explanation of this is that the more aggressive tumors are more amenable to treatment with Table 2 are part of an ongoing imaging protocol designed to evaluate the prognostic value of PET measurements made prior to surgical resection of the tumors. Over the next five years an additional 380 studies will be assessed for heterogeneity and the above survival analysis will be extended to this larger cohort. This will allow a more accurate determination of the potential of the heterogeneity measure for predicting patient survival. However, even at this stage it is clear that the heterogeneity measure developed in this paper has a highly significant association with survival.
AN ANALYSIS OF THE RELIABILITY OF THE HETEROGENEITY ESTIMATOR FOR PET
Our goal is to develop insight into the behavior of the heterogeneity estimator as a function of the accuracy of the underlying image data. The heterogeneity measure is a non-linear functional of the PET data and a priori it is unclear how its accuracy depends on the reliability of the PET data. Based on established results for density estimation (see Silverman (1986) for example), the maximum SUV used in the sarcoma analysis of the previous section is a functional which, in statistical terms, would be expected to converge only non-parametrically as a function of the reliability of the PET data. On the other hand, sufficiently smooth functionals would be expected to have an optimal parametric rate of convergence. Bickel and Ritov (1995) established such results for classes of linear functionals in PET. This section shows that under reasonable smoothness assumptions the heterogeneity measure can be expected to have a similar parametric rate of convergence as a function of the injected dose of the radiotracer for the PET study. This behavior may well contribute to the value of the heterogeneity measure as a prognostic indicator of patient survival in the sarcoma setting. The outline of the section is as follows. We begin by reviewing established results concerning the reliability of PET image data. Note that PET images are obtained as a result of a reconstruction (deconvolution) process applied to raw Poisson count data (see O'Sullivan (1995) ). We develop a certain linear approximation for the non-linear heterogeneity estimator. Then we present an analysis of this linear approximation which enables us to draw appropriate conclusions on the statistical convergence of the heterogeneity estimator. Our main result is Theorem 2 which is stated at the end of the section after the technical notation and basic machinery has been introduced. The proof of the theorem is given in the supplementary material posted on http://www.biostatistics.oupjournals.org.
Starting with the landmark discussion paper of Vardi et al. (1985) , the reconstruction problem of PET has received considerable attention in the statistics literature. There have been a number of contributions including a series of studies characterizing the accuracy of PET image data as a function of the injected dose of radioisotope (e.g. Bickel and Ritov (1995) and Johnstone and Silverman (1990) ). The typical result specifies how the norm of the difference between the PET image data and the true source distribution of the radiotracer in the tissue varies as a function of the smoothness of true source and the dose of radiotracer injected, e.g.
where z is the reconstructed PET image data, λ is the true source distribution (assumed to have m orders of Sobolev smoothness), τ is the injected dose in millicuries, d is the dimension of the imaging domain (d = 2 for planar imaging and d = 3 for volumetric imaging) and r is a measure of the difficulty of the PET reconstruction problem (r = 1/2 for planar imaging and r = 1 for volumetric scanners). Note that the above result assumes that the bandwidth of the smoothing filter used in the reconstruction process is selected appropriately (c.f. O'Sullivan and Pawitan (1996) ). To put the above in perspective, with r = 0 we obtain the familiar result for non-parametric estimation of a source distribution (λ) based on a realization of an inhomogeneous Poisson process with intensity τ ·λ. See O'Sullivan and Pawitan (1996), for example. At practical discretization levels and doses, numerical simulations in O'Sullivan (1995) show that in the context of PET the behavior of the reconstruction error as a function of dose is well predicted by the above formula.
To simplify the presentation here, we focus on a slightly simplified situation in which the observed tissue data can be regarded as a function. Thus we write the heterogeneity aŝ
Note in this settingθ τ is the value of θ which minimizes ψ 1τ (θ ) = [z(x) −ĝ θ (t (x|θ))] 2 dx andĝ θ is the level function which minimizes (over monotone choices of f ) the functional [z(x) − f (t (x|θ))] 2 dx. The true heterogeneity ψ is defined analogously in terms of the underlying true source distribution, i.e.
(t (x|θ * ))] 2 dx, θ * is the value of θ which minimizes
] 2 dx and g * θ is the level function which minimizes (again over monotone
The analytic nature of the heterogeneity functional should obviously be expected to determine its statistical performance (i.e. convergence characteristics). With all regular estimators, asymptotic behavior can be deduced from an examination of a first-order linearization. See, for example, Cramer (1946) and Huber (1981) for classical parametric estimators, and Cox and O'Sullivan (1990) for generalizations to classes of non-parametric estimators. In the case at hand, we show that the application of linearization indicates that the deviation between the heterogeneity estimator (ψ τ ) and the true heterogeneity of the tissue (ψ) is asymptotically described by an integrated difference between the reconstructed image data and the underlying source distribution, i.e. as τ increaseŝ
where w is a weighting function. Here the ≈ sign is used to indicate similarity in distribution. The sense of this similarity is developed below.
Construction of the linearization
By first-order Taylor series expansion, if ψ 2 > 0, then
We now derive linear expansions for [ψ 1τ − ψ 1 ] and [ψ 2τ − ψ 2 ], i.e. for some w 1 (x) and w 2 (x):
From this the linear representation forψ τ − ψ would follow with w(
The expansions forψ 1τ andψ 2τ are obtained as follows. We begin withψ 2τ which admits a straightforward analysis. Using the familiar 'a 2 − b 2 = (a + b)(a − b)' identity we havê
Thus we let w 2 (x) = 2λ(x) in the expansion forψ 2τ . The expansion forψ 1τ is more complicated to construct. To begin,
whereθ τ and θ * are defined following equations (5) and (6) above. We now argue that
Here the second line follows because 
Multiplying and rearranging terms gives
We suppose g * 
Since ∂ θ ψ 1 (θ * ) = 0, an expression similar to ψ 1τ (θ * )−ψ 1 (θ * ) above can be derived for ∂ θ ψ 1τ (θ * )−∂ θ ψ 1 (θ * ). Analyzing this expression indicates that θ τ −θ * can at least be bounded above by a term which is O p (τ , and a slight modification to standard arguments (Nychka and Cox, 1989; Wahba, 1990) Proof. The proof is posted at http://www.biostatistics.oupjournals.org.
DISCUSSION
We have proposed a method for evaluation of heterogeneity in 3D bioimaging data. An efficient computational algorithm is provided. Practical application of this method to PET sarcoma data sets suggests that the heterogeneity estimate has definite prognostic potential. An analysis of the largesample behavior of the estimator indicates a simple linear approximation and a parametric convergence characteristic. Thus we can expect the heterogeneity values to be more stable statistically than other functionals such as the maximum FDG utilization within the region of interest that has been used previously (Eary et al., 1998) . More extensive validation of the prognostic value of the heterogeneity measure in the context of PET sarcoma application is now underway. If heterogeneity is demonstrated to be a clinically relevant indicator of patient prognosis, there will be substantial interest in developing measures of uncertainty in heterogeneity values computed for individual patients. In that context the linear approximations developed in this paper could prove to be useful.
The residual sum of squares criterion used in the definition of the heterogeneity could obviously be generalized to include weights. It should be noted, however, that the choice of weights is not merely a matter of incorporating measures of the uncertainty in the pixel-level data. The limiting form of the heterogeneity measure obtained by weighting ultimately needs to have a solid biological/clinical justification. The choice of the idealized structure used in this paper is somewhat arbitrary. Extensions of the methodology to allow for alternatives to the elliptical structure used to define the contour coordinate function are presently being examined. A referee has suggested that it may also be fruitful to explore summaries based on the morphology of the 3D tumor ROI.
